Creative Planning Increases Holdings in West Pharmaceutical Services, Inc. (NYSE:WST)

Creative Planning increased its holdings in shares of West Pharmaceutical Services, Inc. (NYSE:WST) by 7.5% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 50,371 shares of the medical instruments supplier’s stock after purchasing an additional 3,526 shares during the quarter. Creative Planning’s holdings in West Pharmaceutical Services were worth $15,119,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in WST. Sumitomo Mitsui Trust Holdings Inc. grew its holdings in West Pharmaceutical Services by 1.5% during the 1st quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 191,469 shares of the medical instruments supplier’s stock valued at $75,766,000 after buying an additional 2,759 shares in the last quarter. Mizuho Markets Americas LLC grew its stake in West Pharmaceutical Services by 142.3% during the first quarter. Mizuho Markets Americas LLC now owns 29,628 shares of the medical instruments supplier’s stock valued at $11,724,000 after acquiring an additional 17,399 shares in the last quarter. AMI Asset Management Corp increased its holdings in West Pharmaceutical Services by 3.3% in the 1st quarter. AMI Asset Management Corp now owns 164,738 shares of the medical instruments supplier’s stock valued at $65,188,000 after acquiring an additional 5,217 shares during the last quarter. Tidal Investments LLC lifted its stake in West Pharmaceutical Services by 54.7% in the 1st quarter. Tidal Investments LLC now owns 10,574 shares of the medical instruments supplier’s stock worth $4,181,000 after purchasing an additional 3,738 shares in the last quarter. Finally, SG Americas Securities LLC boosted its holdings in shares of West Pharmaceutical Services by 44.4% during the 1st quarter. SG Americas Securities LLC now owns 12,365 shares of the medical instruments supplier’s stock valued at $4,893,000 after purchasing an additional 3,802 shares during the last quarter. Institutional investors own 93.90% of the company’s stock.

West Pharmaceutical Services Trading Down 2.1 %

Shares of WST stock opened at $287.25 on Tuesday. The company has a current ratio of 2.34, a quick ratio of 1.68 and a debt-to-equity ratio of 0.03. The stock has a market capitalization of $20.84 billion, a price-to-earnings ratio of 40.86, a price-to-earnings-growth ratio of 10.46 and a beta of 1.01. West Pharmaceutical Services, Inc. has a 12-month low of $265.00 and a 12-month high of $413.70. The stock’s 50-day moving average price is $299.96 and its 200-day moving average price is $324.52.

West Pharmaceutical Services (NYSE:WST) last released its quarterly earnings data on Thursday, July 25th. The medical instruments supplier reported $1.52 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.74 by ($0.22). The firm had revenue of $702.10 million during the quarter, compared to the consensus estimate of $729.36 million. West Pharmaceutical Services had a return on equity of 19.17% and a net margin of 18.25%. The business’s revenue was down 6.9% compared to the same quarter last year. During the same period in the previous year, the firm earned $2.11 EPS. Equities research analysts predict that West Pharmaceutical Services, Inc. will post 6.42 EPS for the current fiscal year.

Insider Buying and Selling at West Pharmaceutical Services

In other news, VP Charles Witherspoon sold 1,029 shares of the business’s stock in a transaction dated Monday, August 19th. The shares were sold at an average price of $300.00, for a total value of $308,700.00. Following the sale, the vice president now directly owns 1,478 shares in the company, valued at $443,400. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. 0.53% of the stock is owned by company insiders.

West Pharmaceutical Services Company Profile

West Pharmaceutical Services, Inc designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products.